H3P36: A Drug Target / Disease Biomarker (G100287087)

Target Name: H3P36

NCBI ID: G100287087

H3P36

Other Name(s): H3F3BP1 | H3 histone pseudogene 36 | p46

H3P36: A Drug Target / Disease Biomarker

H3P36 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the H3P family, which includes proteins that play a critical role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

H3P36 has been identified as a potential drug target or biomarker due to its unique structure and the studies that have been conducted on its function. One of the key reasons for its potential as a drug target is its unique three-dimensional structure, which allows it to interact with small molecules in a controlled manner. This structure allows for the development of small molecules that can modulate its activity, such as drugs that can inhibit its activity and prevent it from participating in cellular processes.

Another reason for its potential as a drug target is its role in the regulation of apoptosis, which is the process by which cells undergo programmed cell death. H3P36 has been shown to play a critical role in the regulation of apoptosis, and studies have suggested that it may be a potential drug target for the treatment of various diseases. For example, studies have shown that H3P36 is involved in the regulation of apoptosis in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its role in apoptosis, H3P36 has also been shown to be involved in the regulation of cell growth and the development of cancer. Studies have suggested that H3P36 may be a potential drug target for the treatment of cancer, due to its involvement in the regulation of cell growth and the development of cancer.

The structure of H3P36 also makes it a unique biomarker, as it can be used to diagnose and monitor various diseases. For example, studies have shown that H3P36 is expressed in various tissues of the body, including the brain, heart, and kidneys, which makes it a potential biomarker for a variety of diseases. In addition, its unique three-dimensional structure makes it difficult to target, which could make it an attractive target for small molecules.

In conclusion, H3P36 is a protein that has unique structure and has been shown to play a critical role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. Its potential as a drug target or biomarker makes it an attractive target for the development of new treatments for various diseases. Further studies are needed to fully understand its role in the regulation of cellular processes and its potential as a drug target.

Protein Name: H3 Histone Pseudogene 36

The "H3P36 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3P36 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets